Tiara™ Transcatheter Mitral Valve Replacement Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 157 participants.
Also called NCT03039855
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 157 participants
- Sponsor
- Registry
-
NCT03039855
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany, Israel, Italy, Netherlands, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03039855. Allocation not applicable; no masking; primary purpose treatment. Start 2017-03-08 (actual); primary completion 2019-12-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tiara™ Transcatheter Mitral Valve Replacement Study
- Acronym
- TIARA-II
- Condition
- Mitral Valve Regurgitation
- Intervention (Device)
- TIARA valve and transapical delivery system
- Lead sponsor
- Shockwave Medical, Inc.
Record details
- Record id
cardio:ct-nct03039855- Content hash
6116881be8dc1603be30e3dcceac95786ca2a454b4547aef244579736fbc9e2d